Skip to main content

Tag School of Veterinary Medicine

Notable graduates: Sara Greenslit — Novelist grabs second career in animal care

May 13, 2008

Sara Greenslit, a returning adult student, has always had dual interest in art and science. She completed a pre-veterinary degree in biology at the College of Charleston, S.C., in 1992.

T cell immunity enhanced by timing of interleukin-7 therapy

February 1, 2008

That the cell nurturing growth factor interleukin-7 can help ramp up the ability of the immune system to remember the pathogenic villains it encounters is well known.

Low vaccination rate of U.S. puppies and kittens poses larger risks

January 22, 2008

It's hard to believe that in an advanced country like the United States, fewer than half of all puppies and kittens are being vaccinated. Yet that's exactly what was found in a study recently completed by UW–Madison and Dane County veterinarians.

Wisconsin veterinarian honored by American Association of Bovine Practitioners

October 2, 2007

Garrett R. Oetzel, a food animal production medicine veterinarian at the University of Wisconsin–Madison School of Veterinary Medicine, received the 2007 AABP Alpharma Award of Excellence during the American Association of Bovine Practitioners (AABP) annual meeting in Vancouver, British Columbia, Canada on September 22, 2007.

Major donor underwrites Equine Veterinary Referral Center

September 11, 2007

The new Morrie Waud Equine Center, a facility designed to train veterinary medicine students from the University of Wisconsin–Madison, is now officially open for business.

New ophthalmologist joins School of Veterinary Medicine

August 30, 2007

Elizabeth Adkins, a board-certified veterinary ophthalmologist, has joined the staff at the University of Wisconsin–Madison School of Veterinary Medicine, effective Aug. 22.

Features of replication suggest viruses have common themes, vulnerabilities

August 14, 2007

A study of the reproductive apparatus of a model virus is bolstering the idea that broad classes of viruses - including those that cause important human diseases such as AIDS, SARS and hepatitis C - have features in common that could eventually make them vulnerable to broad-spectrum antiviral agents.